Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shu Soeda

Showing results (61-70 of 68) with videos related to

Pageof 7
Sort By:
You have reached the last page of results.This site can display upto 68 results.
Anticancer Research|August 28, 2025
Multidisciplinary Therapy of Uterine Ewing's Sarcoma With the Preservation of Uterus and Ovarian Function by Laparoscopy: A Case Report and Literature ReviewShigenori Furukawa, Shu Soeda, Hisahito Endo, et al.
Cancer Chemotherapy and Pharmacology|June 29, 2017
A phase II study of irinotecan and pegylated liposomal doxorubicin in platinum-resistant recurrent ovarian cancer (Tohoku Gynecologic Cancer Unit 104 study)Tadahiro Shoji, Eriko Takatori, Hideo Omi, et al.
Molecular and Clinical Oncology|December 14, 2019
Clinical and reproductive outcomes of fertility-sparing surgery in stage I epithelial ovarian cancerTakafumi Watanabe, Shu Soeda, Hiroshi Nishiyama, et al.
International Journal of Clinical Oncology|January 20, 2016
Clinical efficacy of nedaplatin-based concurrent chemoradiotherapy for uterine cervical cancer: a Tohoku Gynecologic Cancer Unit StudyMasahiro Kagabu, Tadahiro Shoji, Kazuyuki Murakami, et al.
International Journal of Clinical Oncology|October 10, 2022
Comparison of treatment outcomes between first-line chemotherapy with or without bevacizumab for advanced ovarian, fallopian tube, and primary peritoneal cancer (Tohoku gynecologic cancer unit: TGCU-RS001 study)Tadahiro Shoji, Eriko Takatori, Takayuki Nagasawa, et al.
Cancers|November 27, 2024
Comparison of Treatment Outcomes Between First-Line Chemotherapy With or Without Bevacizumab for Advanced Ovarian Clear Cell Carcinoma (Tohoku Gynecologic Cancer Unit: TGCU-RS001A Study)Tadahiro Shoji, Eriko Takatori, Takayuki Nagasawa, et al.
Journal of Gynecologic Oncology|February 13, 2026
Clinical and prognostic insights into Trousseau's syndrome in gynecologic malignancies: a multicenter studyHemian Zhang, Masayuki Futagami, Rie Miura, et al.
International Journal of Clinical Oncology|January 8, 2014
Paclitaxel-carboplatin for advanced or recurrent carcinosarcoma of the uterus: the Japan Uterine Sarcoma Group and Tohoku Gynecologic Cancer Unit StudyTadao Takano, Takeo Otsuki, Hideki Tokunaga, et al.
Pageof 7

Showing results (61-70 of 68) with videos related to

Sort By:
Pageof 7
You have reached the last page of results.This site can display upto 68 results.
Anticancer Research|August 28, 2025
Multidisciplinary Therapy of Uterine Ewing's Sarcoma With the Preservation of Uterus and Ovarian Function by Laparoscopy: A Case Report and Literature ReviewShigenori Furukawa, Shu Soeda, Hisahito Endo, et al.
Cancer Chemotherapy and Pharmacology|June 29, 2017
A phase II study of irinotecan and pegylated liposomal doxorubicin in platinum-resistant recurrent ovarian cancer (Tohoku Gynecologic Cancer Unit 104 study)Tadahiro Shoji, Eriko Takatori, Hideo Omi, et al.
Molecular and Clinical Oncology|December 14, 2019
Clinical and reproductive outcomes of fertility-sparing surgery in stage I epithelial ovarian cancerTakafumi Watanabe, Shu Soeda, Hiroshi Nishiyama, et al.
International Journal of Clinical Oncology|January 20, 2016
Clinical efficacy of nedaplatin-based concurrent chemoradiotherapy for uterine cervical cancer: a Tohoku Gynecologic Cancer Unit StudyMasahiro Kagabu, Tadahiro Shoji, Kazuyuki Murakami, et al.
International Journal of Clinical Oncology|October 10, 2022
Comparison of treatment outcomes between first-line chemotherapy with or without bevacizumab for advanced ovarian, fallopian tube, and primary peritoneal cancer (Tohoku gynecologic cancer unit: TGCU-RS001 study)Tadahiro Shoji, Eriko Takatori, Takayuki Nagasawa, et al.
Cancers|November 27, 2024
Comparison of Treatment Outcomes Between First-Line Chemotherapy With or Without Bevacizumab for Advanced Ovarian Clear Cell Carcinoma (Tohoku Gynecologic Cancer Unit: TGCU-RS001A Study)Tadahiro Shoji, Eriko Takatori, Takayuki Nagasawa, et al.
Journal of Gynecologic Oncology|February 13, 2026
Clinical and prognostic insights into Trousseau's syndrome in gynecologic malignancies: a multicenter studyHemian Zhang, Masayuki Futagami, Rie Miura, et al.
International Journal of Clinical Oncology|January 8, 2014
Paclitaxel-carboplatin for advanced or recurrent carcinosarcoma of the uterus: the Japan Uterine Sarcoma Group and Tohoku Gynecologic Cancer Unit StudyTadao Takano, Takeo Otsuki, Hideki Tokunaga, et al.
Pageof 7